Academic Journal
Extended haplotypes at the complement factor H gene locus are associated with liver transplant rejection.
| Τίτλος: | Extended haplotypes at the complement factor H gene locus are associated with liver transplant rejection. |
|---|---|
| Συγγραφείς: | Nieuwenhuis LM; Department of Surgery, Section of Hepatopancreatobiliary Surgery and Liver Transplantation, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.; Department of Gastroenterology and Hepatology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Loza BL; Department of Surgery, Penn Transplant Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Berger SP; Department of Internal Medicine, Division of Nephrology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Jansen BH; Department of Gastroenterology and Hepatology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Blokzijl H; Department of Gastroenterology and Hepatology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Daha MR; Department of Internal Medicine, Division of Nephrology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.; Department of Nephrology, Leiden University Medical Center, University of Leiden, Leiden, The Netherlands., Lammerts RGM; Transplantation Immunology, Department of Laboratory Medicine, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Shaked A; Department of Surgery, Penn Transplant Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Asrani S; Baylor University Medical Center, Dallas, Texas, USA., Lisman T; Department of Surgery, Section of Hepatopancreatobiliary Surgery and Liver Transplantation, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Weersma RK; Department of Gastroenterology and Hepatology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Festen EAM; Department of Gastroenterology and Hepatology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., de Meijer VE; Department of Surgery, Section of Hepatopancreatobiliary Surgery and Liver Transplantation, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Poppelaars F; Department of Internal Medicine, Division of Nephrology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands. |
| Συλλογικό Έργο: | TransplantLines Investigators |
| Πηγή: | Hepatology communications [Hepatol Commun] 2026 Jul 15; Vol. 10 (8). Date of Electronic Publication: 2026 Jul 15 (Print Publication: 2026). |
| Τύπος έκδοσης: | Journal Article |
| Γλώσσα: | English |
| Στοιχεία περιοδικού: | Publisher: Wolters Kluwer Health, Inc Country of Publication: United States NLM ID: 101695860 Publication Model: eCollection Cited Medium: Internet ISSN: 2471-254X (Electronic) Linking ISSN: 2471254X NLM ISO Abbreviation: Hepatol Commun Subsets: MEDLINE |
| Imprint Name(s): | Publication: 2023- : [Philadelphia] : Wolters Kluwer Health, Inc. Original Publication: [Hoboken, NJ] : Wiley Periodicals, Inc. on behalf of the American Association for the Study of Liver Diseases, [2017]- |
| Ιατρικοί όροι (MeSH): | Liver Transplantation*/adverse effects , Graft Rejection*/genetics , Graft Rejection*/immunology , Complement Factor H*/genetics , Complement C3b Inactivator Proteins*/genetics, Haplotypes ; Humans ; Male ; Female ; Kaplan-Meier Estimate ; Blood Proteins |
| Περίληψη: | Background: Acute T-cell-mediated rejection (ACR) remains an important complication after liver transplantation. Polymorphisms in the factor H gene (CFH) and factor H-related protein genes (CFHRs) affect the risk of multiple complement-related diseases. Given the complement system's key role in alloimmunity, we hypothesized that variants in CFH and CFHRs associate with ACR risk after liver transplantation. Methods: In 689 donor-recipient pairs, the deletion of CFHR1 and CFHR3 (CFHR3,1Δ), a low-expression variant of CFHR2, and CFH haplotypes were extracted from both donor and recipient genotypes following appropriate imputation and quality control steps. Results: Kaplan-Meier survival curves and multivariable Cox regression analysis showed increased ACR incidence after transplantation of donor livers carrying 2 copies of the CFHR3,1Δ (log-rank p=0.03, HR: 2.76, 95% CI: 1.18-6.45) or the related CFH-H4a haplotype (log-rank p=0.03, HR: 1.65, 95% CI: 1.04-2.63). In contrast, a lower ACR incidence was observed after transplanting donor livers with a low-expressing CFHR2 variant (log-rank p=0.04, HR: 0.66, 95% CI: 0.45-0.96) or the related CFH-H2 haplotype (log-rank p=0.01, HR: 0.58, 95% CI: 0.37-0.92). When analyzing recipient genotypes, only CFHR3,1Δ was associated with ACR (log-rank: p=0.01, HR: 2.55, 95% CI: 1.15-5.65). Conclusions: Common functional variants in the CFH-CFHR region are associated with rejection risk after liver transplantation, highlighting a previously overlooked relevance of the complement system in liver transplantation. (Copyright © 2026 The Author(s). Published by Wolters Kluwer Health, LLC. on behalf of the American Association for the Study of Liver Diseases.) |
| References: | Biomedicines. 2023 Jul 23;11(7):. (PMID: 37509709) Am J Hum Genet. 2021 Aug 5;108(8):1367-1384. (PMID: 34260947) Clin Exp Immunol. 2008 Jan;151(1):1-13. (PMID: 18081690) Int J Hepatol. 2021 May 23;2021:6636456. (PMID: 34123432) Science. 2021 Nov 12;374(6569):eabj1541. (PMID: 34648354) Nature. 1967 Jun 3;214(5092):1042-3. (PMID: 6059034) Nat Genet. 2006 Oct;38(10):1173-7. (PMID: 16998489) Proc Natl Acad Sci U S A. 2005 May 17;102(20):7227-32. (PMID: 15870199) BMJ Open. 2018 Dec 31;8(12):e024502. (PMID: 30598488) Am J Transplant. 2023 Apr;23(4):484-497. (PMID: 36746335) Nucleic Acids Res. 2025 Jan 6;53(D1):D948-D957. (PMID: 39656687) Hum Genet. 2009 Mar;125(2):131-51. (PMID: 19184668) Invest Ophthalmol Vis Sci. 2016 May 1;57(6):2763-9. (PMID: 27196323) Hepatol Commun. 2024 Dec 11;9(1):. (PMID: 39670865) J Innate Immun. 2025;17(1):244-261. (PMID: 40139172) Front Immunol. 2020 Jul 16;11:1297. (PMID: 32765490) Front Immunol. 2021 Mar 30;12:660194. (PMID: 33868311) Front Immunol. 2023 Jun 16;14:1186653. (PMID: 37398677) Nat Genet. 2024 Dec;56(12):2659-2671. (PMID: 39623103) J Exp Med. 2007 Jun 11;204(6):1249-56. (PMID: 17517971) Transplantation. 2024 Sep 1;108(9):1882-1894. (PMID: 38361233) J Clin Exp Hepatol. 2017 Dec;7(4):358-366. (PMID: 29234201) Kidney Int Rep. 2022 Sep 06;7(11):2484-2494. (PMID: 36531875) Transpl Immunol. 2019 Apr;53:7-12. (PMID: 30472391) J Am Soc Nephrol. 2015 May;26(5):1195-204. (PMID: 25205734) Mol Immunol. 2017 Apr;84:77-83. (PMID: 27989433) Front Immunol. 2024 Jul 29;15:1447991. (PMID: 39136026) Am J Transplant. 2021 Sep;21(9):3133-3147. (PMID: 33445220) J Clin Invest. 2025 Jun 16;135(12):. (PMID: 40519165) J Innate Immun. 2025;17(1):226-243. (PMID: 40139166) Nat Rev Immunol. 2012 May 25;12(6):431-42. (PMID: 22627861) PLoS Genet. 2011 May;7(5):e1002079. (PMID: 21637784) Immunol Rev. 2023 Jan;313(1):71-90. (PMID: 36089777) Immunobiology. 2012 Feb;217(2):265-71. (PMID: 21899915) Proc Natl Acad Sci U S A. 2018 May 8;115(19):E4433-E4442. (PMID: 29686068) Nature. 2024 May;629(8012):624-629. (PMID: 38632401) PLoS Genet. 2007 Mar 16;3(3):e41. (PMID: 17367211) Nat Commun. 2019 Jul 4;10(1):2961. (PMID: 31273197) Nat Rev Immunol. 2024 Feb;24(2):118-141. (PMID: 37670180) Am J Transplant. 2015 Apr;15(4):1003-13. (PMID: 25772599) Transpl Int. 2020 Dec;33(12):1779-1787. (PMID: 32990344) Hum Pathol. 2022 Sep;127:67-77. (PMID: 35728694) J Immunol. 2017 Jul 1;199(1):292-303. (PMID: 28533443) Front Immunol. 2026 Jan 14;16:1621317. (PMID: 41613109) Sci Rep. 2025 Mar 28;15(1):10669. (PMID: 40148491) Am J Hum Genet. 2021 Aug 5;108(8):1385-1400. (PMID: 34260948) PLoS One. 2013 Apr 16;8(4):e60352. (PMID: 23613724) Nat Commun. 2024 Jan 10;15(1):443. (PMID: 38200010) Nat Med. 2022 May;28(5):999-1005. (PMID: 35393535) |
| Contributed Indexing: | Keywords: acute cellular rejection; genetics; immunology; liver disease; liver transplantation |
| Substance Nomenclature: | 80295-65-4 (Complement Factor H) 0 (Complement C3b Inactivator Proteins) 0 (CFHR3 protein, human) 0 (CFHR1 protein, human) 0 (Blood Proteins) |
| Entry Date(s): | Date Created: 20260722 Date Completed: 20260722 Latest Revision: 20261017 |
| Update Code: | 20261017 |
| PubMed Central ID: | PMC13671603 |
| DOI: | 10.1097/HC9.0000000000000997 |
| PMID: | 42486812 |
| Βάση Δεδομένων: | MEDLINE |
καταχωρήστε σχόλιο πρώτοι!